Literature DB >> 25560573

Impact of sparfloxacin on melanogenesis and antioxidant defense system in normal human melanocytes HEMa-LP - An in vitro study.

Artur Beberok1, Dorota Wrześniok2, Michał Otręba2, Ewa Buszman2.   

Abstract

BACKGROUND: Fluoroquinolones are a group of broad spectrum bactericidal antibiotics used to treat various infections of urinary and respiratory systems, as well as in ophthalmology and dermatology. This class of antibiotics causes toxic effects directed to pigmented tissues, what introduces a serious limitation to their use. The aim of this work was to examine the impact of sparfloxacin on melanogenesis and the antioxidant defense system in normal human epidermal melanocytes, adult, lightly pigmented (HEMa-LP).
METHODS: The effect of sparfloxacin on cell viability was determined by WST-1 assay; melanin content, tyrosinase activity as well as antioxidant enzymes activity were measured spectrophotometrically.
RESULTS: Sparfloxacin induced the concentration - dependent loss in melanocytes viability. The value of EC50 was determined to be ∼0.25 mM. Sparfloxacin inhibited tyrosinase activity and reduced the melanin content in human melanocytes. To study the antioxidant defense system in melanocytes, the activities of superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx) in cells exposed to sparfloxacin were determined. It was observed that sparfloxacin caused depletion of the antioxidant status of melanocytes.
CONCLUSIONS: The observed sparfloxacin-dependent inhibition of melanogenesis and changes of antioxidant enzymes activities in human melanocytes give a new insight into the mechanism of fluoroquinolones toxicity directed to pigmented tissues.
Copyright © 2014 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.

Entities:  

Keywords:  Antioxidant enzymes; Melanization; Melanocytes; Sparfloxacin; Tyrosinase

Mesh:

Substances:

Year:  2014        PMID: 25560573     DOI: 10.1016/j.pharep.2014.07.015

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  5 in total

1.  Proton pump inhibitors decrease melanogenesis in melanocytes.

Authors:  Seung-Hwa Baek; Sang-Han Lee
Journal:  Biomed Rep       Date:  2015-07-17

2.  Changes in the Oxidation-Reduction State of Human Dermal Fibroblasts as an Effect of Lomefloxacin Phototoxic Action.

Authors:  Justyna Kowalska; Klaudia Banach; Zuzanna Rzepka; Jakub Rok; Marta Karkoszka; Dorota Wrześniok
Journal:  Cells       Date:  2022-06-19       Impact factor: 7.666

3.  Aqueous humor tyrosinase activity is indicative of iris melanocyte toxicity.

Authors:  Sarmistha Mahanty; Ankush A Kawali; Shruthi Shirur Dakappa; Padmamalini Mahendradas; Mathew Kurian; Varun Kharbanda; Rohit Shetty; Subba Rao Gangi Setty
Journal:  Exp Eye Res       Date:  2017-07-13       Impact factor: 3.467

4.  The Biochemical and Molecular Analysis of Changes in Melanogenesis Induced by UVA-Activated Fluoroquinolones-In Vitro Study on Human Normal Melanocytes.

Authors:  Justyna Kowalska; Klaudia Banach; Artur Beberok; Jakub Rok; Zuzanna Rzepka; Dorota Wrześniok
Journal:  Cells       Date:  2021-10-27       Impact factor: 6.600

5.  Lomefloxacin Induces Oxidative Stress and Apoptosis in COLO829 Melanoma Cells.

Authors:  Artur Beberok; Dorota Wrześniok; Martyna Szlachta; Jakub Rok; Zuzanna Rzepka; Michalina Respondek; Ewa Buszman
Journal:  Int J Mol Sci       Date:  2017-10-20       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.